The Elderly ACS II Trial
Phase IV: A Comparison of Reduced-dose Prasugrel and Clopidogrel in Elderly Patients With Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention (PCI)
Sponsor: A. Manzoni Hospital
This PHASE4 trial investigates Acute Coronary Syndrome and Cardiovascular Diseases and is currently completed. A. Manzoni Hospital leads this study, which shows 9 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
9 versions recorded-
Jul 2025 — Present [monthly]
Completed PHASE4
Status: Unknown → Completed
-
Apr 2025 — Jul 2025 [monthly]
Unknown PHASE4
-
Mar 2025 — Apr 2025 [monthly]
Unknown PHASE4
-
Sep 2024 — Mar 2025 [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
▶ Show 4 earlier versions
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Nov 2018 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Nov 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- A. Manzoni Hospital
- ANMCO Italian Association of Hospital Cardiologist
- Azienda USL Reggio Emilia - IRCCS
- Italian Society of Invasive Cardiology
For direct contact, visit the study record on ClinicalTrials.gov .